2020 Detroit Multiple Sclerosis Conference Agenda

Due to ongoing health concerns regarding the spread of coronavirus (COVID-19), the 2020 Detroit MS Conference scheduled to be held Friday, March 20 at Henry Ford Hospital will be postponed. The health and safety of our patients, team members and guests is our top priority. We are continuing to monitor the situation and will announce the rescheduled date as soon as possible. Refunds will be issued to all registered attendees as appropriate. For questions, contact the Continuing Medical Education office at (313) 916-3905.

Time

Topic

Speaker

7:00 a.m.

Registration and Breakfast

 

8:00 a.m.

Welcome and Introduction

Mirela Cerghet, M.D., PhD
Director, MS Program,
Department of Neurology,
Henry Ford Health System

Gregory L. Barkley, M.D.
Interim Chair, Department of Neurology
Henry Ford Health System

8:10 a.m.

Keynote: B-Cell Story in Multiple Sclerosis

Robert Lisak, M.D.
Parker Webber Chair in Neurology,
Professor of Neurology
Professor of Biochemistry, Microbiology and Immunology,
Wayne State University

8:45 a.m.

MS Diagnosis Criteria and Phenotype: Recent Updates

Mirela Cerghet, M.D., PhD
Director, MS Program,
Department of Neurology,
Henry Ford Health System

9:00 a.m.

Relapsing Multiple Sclerosis Treatment: Updates

Helena Bulka, D.O.
MS Neurologist,
Department of Neurology,
Henry Ford Health System

9:25 a.m.

Neurogenic Bladder in MS

Humphrey O. Atiemo, M.D.
Chief, Female Pelvic Medicine & Reconstructive Surgery
Department of Urology,
Henry Ford Health System

9:50 a.m.

Q & A

 

9:55 a.m.

Break

 

10:05 a.m.

Secondary Progressive MS Treatment: Updates

Anza B Memon, M.D.
MS Neurologist,
Department of Neurology,
Henry Ford Health System

10:35 a.m.

Primary Progressive MS Treatment: Updates

Mirela Cerghet, M.D., PhD
Director, MS Program,
Department of Neurology,
Henry Ford Health System

10:50 a.m.

Keynote: Stem Cell Therapy in MS

Mark Freedman, M.D.
Director, Multiple Sclerosis Research Unit, Neurology
Ottawa Hospital

11:20 a.m.

Keynote: Induction Therapy vs. When to Escalate Therapy

Adil Javed, M.D., PhD
Associate Professor of Neurology,
Department of Neurology,
University of Chicago

11:50 p.m.

Q & A


12:00 p.m.

Lunch

 

1:00 p.m.

Keynote: Biomarkers in MS: Can we Use Them in the Future?

Yang Mao-Draayer, M.D., PhD
Clinical Professor of Neurology,
Multiple Sclerosis Center/ Holtom-Garrett Neuroimmunology Program, Michigan Medicine

1:35 p.m.
Differential Diagnosis and Misdiagnosis of Multiple Sclerosis
Staton Elias, M.D.
Chair Emeritus, Department of Neurology
Henry Ford Health System

2:05 p.m.

Q & A

 

2:15 p.m.

Break

 

2:30 p.m.

Radiographic Aspects of MS: Updates on MRI Imaging

Brent Griffith, M.D.
Director, Diagnostic Radiology,
Department of Radiology,
Henry Ford Health System

2:50 p.m.

Trigeminal Neuralgia Treatment

Jason M. Schwalb, M.D.
Surgical Director of Movement Disorders and Comprehensive Epilepsy Centers
Department of Neurosurgery,
Henry Ford Health System

3:10 p.m.

Baclofen Pump for Treatment of Spasticity in MS

Maria Humayun, D.O.
Physiatrist,
Department of Neurology
Henry Ford Health System

3:30 p.m.

Coordinating Patient Support in MS Care

Suzanne Croll, RN
MS Clinic Coordinator,
Department of Neurology,
Henry Ford Hospital

3:45 p.m.

NMO and MOG Updates

Anza B Memon, M.D.
MS Neurologist,
Department of Neurology,
Henry Ford Health System

4:05 p.m.

Q & A

 

4:10 p.m.

Conference Summary & Highlights

Mirela Cerghet, M.D., PhD
Director, MS Program,
Department of Neurology
Henry Ford Health System

4:20 p.m.

Adjourn

 


ACCREDITATION STATEMENT:
Henry Ford Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT:
Henry Ford Health System designates this live course for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT:
In compliance with the ACCME standards for commercial support, all individuals in a position to control/influence the content of this activity are required to disclose relevant financial interests of their own or spouse or partners with any commercial interests and/or non-FDA approved use of a drug or a device that is included in the presentation.

HEARING IMPAIRED STATEMENT:
Henry Ford Health System is committed to ensuring that our guests who are deaf or hard-of-hearing have equal access to all the services provided at our facilities. We provide at no cost the appropriate auxiliary aids and services. To request an assistive listening device or service, please call (313) 916-3905 or e-mail [email protected]

Schedule Appointment Online

Please call 911 if you have an emergency or urgent medical question.

If you are having symptoms of COVID-19, for your safety, please select a MyChart video visit on demand or call your primary care provider. For symptoms of COVID-19, please visit our website www.henryford.com/coronavirus.

Henry Ford Health System is committed to ensuring our Deaf or hard-of-hearing patients and visitors have equal access to all services. We provide the appropriate auxiliary aids and services, including qualified sign language interpreters, TTYs and other assistive listening devices, at no cost. To request assistance, call 313-916-1896 or email [email protected].

Schedule Appointment for